Showing results (101-110 of 239) with videos related to

Sort By:
Pageof 24
The American Journal of Psychiatry|July 4, 2007
Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparisonRichard S E Keefe, John A Sweeney, Hongbin Gu, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 7, 2013
Lisdexamfetamine dimesylate augmentation in adults with persistent executive dysfunction after partial or full remission of major depressive disorderManisha Madhoo, Richard S E Keefe, Robert M Roth, et al.
The Journal of Clinical Psychiatry|September 7, 2010
Armodafinil as adjunctive therapy in adults with cognitive deficits associated with schizophrenia: a 4-week, double-blind, placebo-controlled studyJohn M Kane, Deepak C D'Souza, Ashwin A Patkar, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 20, 2015
Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in SchizophreniaRichard S E Keefe, Herbert A Meltzer, Nancy Dgetluck, et al.
Journal of Psychiatric Research|May 27, 2017
Establishing the Brief Assessment of Cognition - Short formMax Lam, Mingyuan Wang, Wanping Huang, et al.
Biological Psychiatry|December 13, 2006
NCAM1 and neurocognition in schizophreniaPatrick F Sullivan, Richard S E Keefe, Leslie A Lange, et al.
Early Intervention in Psychiatry|October 29, 2011
The Singapore flagship programme in translational and clinical research in psychosisSiow-Ann Chong, Alastair Campbell, Michael Chee, et al.
Schizophrenia (Heidelberg, Germany)|October 17, 2025
Primary and secondary caregiver burden of cognitive impairment associated with schizophrenia: a qualitative study based on caregiver interviewsSébastien Tulliez, Alessandra Girardi, Matthew Ridley, et al.
Pageof 24